|
For Immediate Release
August 8, 2002
(Washington, DC) - August 8, 2002 -
The Aspirin Foundation of America (AFA) today welcomed
news of a study suggesting that aspirin may help reduce
the risk of pancreatic cancer.
According to research conducted at the University of
Minnesota and published in today's Journal of the National
Cancer Institute, higher frequency of aspirin use in
women to treat other ailments is associated with lower
rates of pancreatic cancer. The study involved over
28,000 postmenopausal women who were surveyed about
their health habits from 1992 to 1999.
Pancreatic cancer is one of the deadliest forms of
the disease, and according to the lead researcher, fifty
percent of patients die within three months of receiving
the diagnosis. Therefore, prevention is critical in
combating the disease.
"We are thrilled that aspirin might be an important
line of defense in preventing pancreatic cancer,"
said Thomas Bryant, MD, president of the AFA. "Aspirin
has been shown to be beneficial in fighting many illnesses
and is a critical part of preventing heart attacks and
strokes in persons who have already suffered a heart
attack or a stroke. We are optimistic about aspirin's
benefits in this new application."
The AFA reminds those considering the regular use of
aspirin to lower the risk of certain diseases to consult
with their physicians before beginning any aspirin therapy.
###
Contact:
Caroline Perrin
807 National Press Building, Washington, DC 20036
Phone: 800-432-3247 Fax: 202/737-8406
info@aspirin.org
|
